首页 | 本学科首页   官方微博 | 高级检索  
检索        

三氧化二砷-泊洛沙姆407缓释剂瘤内注射治疗裸鼠人肝癌移植瘤的实验研究
引用本文:张鹏,王文,行利,杜永平,冯佳,保宏祥.三氧化二砷-泊洛沙姆407缓释剂瘤内注射治疗裸鼠人肝癌移植瘤的实验研究[J].临床肿瘤学杂志,2009,14(4):293-296.
作者姓名:张鹏  王文  行利  杜永平  冯佳  保宏祥
作者单位:1.西安第四军医大学西京医院中医科 2兰州军区乌鲁木齐总医院心脏内科 3乌鲁木齐军医学校统计教研室
基金项目:陕西省中医管理局科研招标课题 
摘    要:目的:观察三氧化二砷-泊洛沙姆407(As-P407)缓释剂对裸鼠皮下人肝癌移植瘤的有效性。方法:以人肝癌HepG2细胞为来源建立裸鼠皮下移植瘤模型,实验共分3组:As-P407缓释剂治疗组、As治疗组和生理盐水(NS)对照组,于造模成功后6~8天行瘤体注射,每4天1次,共4次。比较各组抗癌疗效,观察裸鼠体重、肿瘤体积变化、抑瘤率、肿瘤组织病理及骨髓涂片以及裸鼠的存活情况、生存质量。结果:As2O3 P407缓释剂治疗组肿瘤生长受到显著抑制,肿瘤体积较As组小(P<0.05),瘤重分别为(0.257±0.080)g和(0.641±0.109)g,差异有统计学意义(P<0.05);两组与NS对照组瘤重(1.094±0.147)g相比,差异有统计学意义(P<0.05)。治疗后As-P407缓释剂组裸鼠体重大于As组和NS对照组,差异有统计学意义(P<0.05)。各组均未见骨髓抑制现象。结论:As-P407缓释剂瘤内注射,使用安全,可维持局部有效药物浓度、延长作用时间,疗效优于As注射液。

关 键 词:三氧化二砷  泊洛沙姆407  肝癌  介入治疗
收稿时间:2008-11-20
修稿时间:2008-12-25

An experimental study of effects of intratumoral injection of arsenic trioxide poloxamer 407 on nude mice transplants of human hepatocellular carcinoma
ZHANG Peng,WANG Wen,HANG Li,DU Yong-ping,FENG Jia,BAO Hong-xiang.An experimental study of effects of intratumoral injection of arsenic trioxide poloxamer 407 on nude mice transplants of human hepatocellular carcinoma[J].Chinese Clinical Oncology,2009,14(4):293-296.
Authors:ZHANG Peng  WANG Wen  HANG Li  DU Yong-ping  FENG Jia  BAO Hong-xiang
Institution:. )Department of Traditional Chinese Medicine, Xijing Hospital of Fourth Military Medical University, Xi'an 710032, China)
Abstract:Objective: To investigate the therapeutic effects of arsenic trioxide poloxamer 407 (As2 O3-P407) depot preparations on the human hepatocellular carcinoma cell line ( HepG2 ) subcutaneously implanted in nude mice. Methods: Nude mice were subcutaneously transplanted with human HepG2 , and then divided into 3 groups. Test group: the nude mice were treated by As2O3-P407; positive control group: the nude mice were treated with As2O3; blank group: the nude mice were treated with physiological saline. 6-8 days after Modeling success, carry out intratumoral injection. Every four days one time, four times totally. To compare the therapeutic effects of three groups, the weight of the nude mice, the changes of tumor size,the inhibitory rate of tumor,the pathology of tumor,the bone marrow smears ,the survival condition of nude mice. Results :The growth of the tumor of the As2O3-P407 treatment group was significantly inhibited ; the size of the tumor was significant smaller than As2O3 treatment group ( P 〈 0. 05 ) ; the weight of the two groups' tumor were significant different (0. 257±0. 080g vs. 0. 641 ±0. 109g, P 〈0. 05). The weight of the blank group was 1. 094 ±0. 147g and compare with the other two groups, the difference was all significant (P 〈 0. 05 ). The inhibitory rates of humor about As2O3-P407 and As2O3 treatment groups were 72% and 46%. The weight of the As2O3-P407 treated nude mice was heavier than the other two groups, and the difference was significant (P 〈 0. 05 ). Bone marrow suppression phenomenon was not observed in three groups. Conclusion:As3O3-P407 through intratumoral injection exhibits therapeutic effects in relatively big advanced liver cancer, because of the high concentration and prolonged action in the tumor foci. Its comprehensive therapeutic effect is better than absolute As2O3administration.
Keywords:Arsenic trioxide (As2O3 )  Poloxamer407  Hepatocellular carcinoma  Interventional therapy
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号